Gilead Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. 

CEO
Daniel P. O'Day
CEODaniel P. O'Day
Employees
17,000
Employees17,000
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
1987
Founded1987
Employees
17,000
Employees17,000

GILD Key Statistics

Market cap
173.57B
Market cap173.57B
Price-Earnings ratio
20.60
Price-Earnings ratio20.60
Dividend yield
2.28%
Dividend yield2.28%
Average volume
6.88M
Average volume6.88M
High today
$140.71
High today$140.71
Low today
$138.94
Low today$138.94
Open price
$139.12
Open price$139.12
Volume
778.54K
Volume778.54K
52 Week high
$157.29
52 Week high$157.29
52 Week low
$93.37
52 Week low$93.37

Stock Snapshot

Gilead Sciences(GILD) stock is priced at $139.82, giving the company a market capitalization of 173.57B. It carries a P/E multiple of 20.60 and pays a dividend yield of 2.3%.

During the trading session on 2026-04-06, Gilead Sciences(GILD) shares reached a daily high of $140.71 and a low of $138.94. At a current price of $139.82, the stock is +0.6% higher than the low and still -0.6% under the high.

Trading activity shows a volume of 778.54K, compared to an average daily volume of 6.88M.

The stock's 52-week range extends from a low of $93.37 to a high of $157.29.

The stock's 52-week range extends from a low of $93.37 to a high of $157.29.

GILD News

Simply Wall St 20h
Assessing Gilead Sciences Valuation After Its Strong Multi Year Share Price Run

Advertisement Gilead Sciences stock after a solid multi year run Gilead Sciences (GILD) continues to attract interest after multi year total returns, includin...

Assessing Gilead Sciences Valuation After Its Strong Multi Year Share Price Run
TipRanks 5d
Gilead extends tender offer to acquire Arcellx

Gilead Sciences (GILD) extended the expiration of the tender offer to purchase all outstanding shares of common stock of Arcellx (ACLX). The offer remains at a...

TipRanks 6d
Galapagos, Gilead enter pact to collaborate on T cell engager therapies

Galapagos (GLPG) announced that it has entered into a binding agreement with Gilead (GILD) in connection with Gilead’s definitive agreement to acquire all of th...

Analyst ratings

75%

of 32 ratings
Buy
75%
Hold
21.9%
Sell
3.1%

People also own

Based on the portfolios of people who own GILD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.